TP53 and skin cancer: p53 mutations occur in 40–60% of all skin cancers [9, 106] suggesting that direct p53 transcriptional targets (such as the PAI-1 gene) may be activated, repressed, or dysregulated as a consequence of p53 mutation with associated loss or gain of function.